We searched PubMed for articles published in English from 1913 to Nov 2012, using the search terms “tuberculosis”, “vitamin D”, and “ultraviolet radiation”. We sourced further articles from our personal databases, and from references cited in papers identified through the process above.
ReviewVitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis
Introduction
Tuberculosis is the second most common cause of death from infection worldwide.1 Vitamin D deficiency is prevalent across broad geographical boundaries;2, 3, 4, 5 an association between the two could be of major relevance to world health.
Mycobacterium tuberculosis is a human pathogen with efficient transmission and immune evasion strategies.6, 7 After the HIV pandemic, tuberculosis re-emerged as a global emergency,8 peaking in 2006 to more than 9 million cases annually, then falling to an estimated 8·8 million by 2010.1 The Stop TB Partnership has an ambitious goal to eliminate tuberculosis by 2050 (to less than one case per 1 million every year).9 Traditionally classified as either latent or active disease, the outcome of infection with M tuberculosis is now perceived as a continuum.10, 11 For clarity, in this Review we refer to latent tuberculosis infection and active tuberculosis. Prevention, diagnosis, and management of both active tuberculosis and latent infection remain challenging, despite substantial improvements in diagnostic tests,12, 13 new drugs for active tuberculosis,14, 15, 16 and new regimens for latent infection.17
Drawbacks with tuberculosis treatment regimens, particularly rising drug resistance and HIV–tuberculosis co-infection, are driving the need for novel treatment approaches. Strategies to accelerate recovery and reduce treatment durations include the development of new antimicrobial agents and the investigation of adjunctive immunotherapies; both are priority areas of tuberculosis research.18 Mechanisms of action of potential adjunctive treatments include promotion of T-helper-1 (Th1) antimycobacterial immune responses (eg, administration of interferon gamma),19 upregulation of host innate (ie, macrophage) antimycobacterial immune responses (eg, vitamin D and nitric oxide),20 decrease of immunopathology mediated tissue damage because of excessive inflammatory responses (eg, corticosteroids),21 and alteration of the metabolic state of tuberculosis bacilli to shift them out of a non-replicative, antibiotic-resistant state (eg, tumour necrosis factor α [TNFα] inhibitors).22 There has been much hope that vitamin D might fulfil at least some of these actions as a potential adjunctive treatment in active or latent tuberculosis.
Vitamin D is derived from endogenous synthesis after exposure of the skin to solar ultraviolet radiation. Receptors for its active form, 1,25-dihydroxyvitamin D, are widely expressed in human cells, including monocytes and macrophages, dendritic, T cells, B cells, and natural killer cells.23 The effects of 1,25-dihydroxyvitamin D are immunostimulatory in monocytes and macrophages and immunosuppressive in dendritic and T cells. Ultraviolet radiation causes immune changes too, mainly downregulatory, in antigens encountered close to the time of the exposure.24, 25
Basic science,26, 27 clinical research,28, 29, 30 population studies,31 and historical treatment practices (eg, phototherapy and cod-liver oil)32, 33 suggest that inexpensive, accessible vitamin D could play an important part in the treatment of tuberculosis. Sufficiency in vitamin D has been hypothesised to decrease the risk of infection with tuberculosis after exposure,34 limits the progression from latent to active tuberculosis,35 and, as an adjunct to antimicrobial treatment, decreases the duration and improves the effectiveness of treatment.20, 28, 30
Questions about the relation between tuberculosis, vitamin D, and ultraviolet radiation are largely unexplored. These include reconciliation of contradictory immunological actions of 1,25-dihydroxyvitamin D related to the balance between innate immunity (antimicrobial peptides and macrophages in particular) and adaptive immunity, understanding of the immunological effects of exposure to ultraviolet radiation (a potentially important confounder of the vitamin D–tuberculosis relation), and consideration of alternative hypotheses that explain the common finding of low vitamin D status in patients with active tuberculosis. We reviewed the scientific literature to provide evidence, explore contradictions, and suggest alternative hypotheses.
Section snippets
Background
When 7-dehydrocholesterol in the plasma membrane of human keratinocytes is exposed to ultraviolet B (UVB) radiation, it is converted to previtamin D3, followed by a thermal reaction to form vitamin D3 (cholecalciferol). Some foods contain vitamin D3 or vitamin D2, which is synthesised by plants after UVB irradiation; however, these only contribute small amounts of the total vitamin D requirements in most individuals. The physiological effects of D2 and D3 are interchangeable, although oral
Ultraviolet radiation-induced immunological effects and tuberculosis
Ultraviolet radiation is the major source of vitamin D and its immunological effects should therefore be assessed alongside those of vitamin D.94 Exposure of animals and human beings to ultraviolet light results in downregulation of T and B-cell response to various antigens, including tumour antigens, contact sensitisers, microorganisms, and alloantigens.25 Immunomodulation pathways vary depending on the antigen; the spectrum, dose and frequency of radiation exposure, time between exposure and
Historical perspective
In the 19th century, cod-liver oil was used in Europe to prevent childhood diseases such as rickets and tuberculosis.33, 108 Although not a cure, a benefit in patients with tuberculosis was weight gain.108 It was sometimes given in large doses (0·5–1·0 pint every 4–8 days or one or two tablespoons two to four times daily). The chemical structures of the vitamins D were discovered by Windaus and colleagues109 in the 1930s and the antirachitic component of cod-liver oil, identified in rats, was
Clinical trials of vitamin D supplementation
Although observational studies justify trials of vitamin D supplementation to inhibit progression from latent to active tuberculosis, such studies pose difficulties because they need large numbers of patients, long follow-up, and would need to show a clear additional benefit over evidence-based treatments for latent infection (eg, isoniazid preventive treatment and antiretroviral therapy for patients with HIV). Of note, vitamin D supplementation does not decrease the risk of tuberculosis in
Conclusions
The interpretation of studies on vitamin D needs an appreciation of assay variability and the controversies surrounding appropriate serum 25-hydroxyvitamin D reference ranges. Vitamin D has both immunosuppressive and immunostimulatory effects, and ultraviolet radiation, an important confounder, has mainly immunosuppressive effects. Whereas historical literature on phototherapy supports the use of vitamin D in patients with tuberculosis, direct mycobactericidal actions of exposure to ultraviolet
Search strategy and selection criteria
References (144)
The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action
Mol Aspects Med
(2008)- et al.
Vitamin D and bone mineral density status of healthy schoolchildren in northern India
Am J Clin Nutr
(2005) - et al.
What's good for the host is good for the bug
Trends Microbiol
(2005) - et al.
Immune evasion by Mycobacterium tuberculosis: living with the enemy
Curr Opin Immunol
(2003) - et al.
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
Lancet
(2011) - et al.
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Lancet
(2012) - et al.
Priorities in tuberculosis research
Lancet
(2006) - et al.
L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis
Trends Microbiol
(2008) - et al.
1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro
Exp Hematol
(2000) - et al.
High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial
Lancet
(2011)
The history of phototherapy: something new under the sun?
J Am Acad Dermatol
Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis
Am J Clin Nutr
Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis
J Biol Chem
Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation
J Invest Dermatol
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
Lancet
Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D
J Nutr
Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls
Am J Clin Nutr
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
Am J Clin Nutr
Recommended summer sunlight exposure levels can produce sufficient (> or =20 ng ml(-1)) but not the proposed optimal (> or =32 ng ml(-1)) 25(OH)D levels at UK latitudes
J Invest Dermatol
Recommended summer sunlight exposure amounts fail to produce sufficient vitamin D status in UK adults of south Asian origin
Am J Clin Nutr
Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study
Lancet
Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients
Tuberculosis (Edinb)
Mechanism of 1alpha,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B
Biochim Biophys Acta
Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin
Cell Host Microbe
Vitamin D(3) down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production
Cytokine
Molecular mechanisms of ultraviolet radiation-induced immunosuppression
Eur J Cell Biol
UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo
J Allergy Clin Immunol
Global tuberculosis report 2012
Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study
Clin Endocrinol
Vitamin D deficiency in early childhood: prevalent in the sunny South Pacific
Public Health Nutr
Tuberculosis
Ann Trop Med Parasitol
The global plan to stop TB 2011–2015. Transforming the fight: towards elimination of tuberculosis 2011
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Nat Rev Microbiol
Understanding latent tuberculosis: a moving target
J Immunol
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update
Ann Intern Med
The diarylquinoline TMC207 for multidrug-resistant tuberculosis
N Engl J Med
Delamanid for multidrug-resistant pulmonary tuberculosis
N Engl J Med
Three months of rifapentine and isoniazid for latent tuberculosis infection
N Engl J Med
IFN-gamma therapy of tuberculosis and related infections
J Interferon Cytokine Res
Corticosteroids for managing tuberculous meningitis
Cochrane Database Syst Rev
Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas
PLoS One
Immunologic parameters of ultraviolet carcinogenesis
J Natl Cancer Inst
The consequences of UV-induced immunosuppression for human health
Photochem Photobiol
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
Science
Vitamin D is required for IFN-{gamma}--mediated antimicrobial activity of human macrophages
Sci Transl Med
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial
Am J Respir Crit Care Med
A single dose of vitamin D enhances immunity to mycobacteria
Am J Respir Crit Care Med
Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis
Int J Epidemiol
Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis
Pharm Hist
Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa
Clin Infect Dis
Cited by (77)
Association of vitamin D levels and risk of latent tuberculosis in the hemodialysis population
2021, Journal of Microbiology, Immunology and InfectionChlorpyrifos alters expression of enzymes involved in vitamin D<inf>3</inf> synthesis in skin cells
2021, Pesticide Biochemistry and PhysiologyVitamin D and risk of acute respiratory infections: Influenza and COVID-19
2020, Nutrition Clinique et MetabolismeNew perspectives on difficult-to-treat tuberculosis based on old therapeutic approaches
2020, International Journal of Infectious DiseasesCitation Excerpt :Interestingly, a recent study showed that vitamin D deficiency was strongly associated with extrapulmonary TB (Pareek et al., 2015). On the basis of these findings, vitamin D supplementation could be kept under consideration for specific population groups, such as MDR/XDR-TB or extrapulmonary TB patients; these groups are expected to increase in Europe (Ralph et al., 2013; Sotgiu et al., 2017a, b; Mondoni et al., 2018a, b; Brighenti et al., 2018). Remarkably, individuals with extrapulmonary disease were those for whom heliotherapy and phototherapy were effective (Scolari, 1936; Palmieri, 1936; Vacchelli, 1936; Jarrett, 2017; McCullough and Lehrer, 2018).
Vitamin D modulates human macrophage response to Mycobacterium tuberculosis DNA
2019, TuberculosisCitation Excerpt :Vit D appears to be crucial for macrophage activation and early Mtb clearance [14–16]. Vit D enhances innate immunity through TLR and IFN-γ, reversal of phagosome maturation arrest, increased expression of various antimicrobial peptides, and induction of autophagy in infected cells, thus restricting Mtb intracellular growth in macrophages [17]. We herein show that Mtb nucleic acid of different lineages elicit differential inflammatory responses in human macrophages.